Detalhe da pesquisa
1.
Adoptive cellular therapy with T cells expressing the dendritic cell growth factor Flt3L drives epitope spreading and antitumor immunity.
Nat Immunol
; 21(8): 914-926, 2020 08.
Artigo
Inglês
| MEDLINE | ID: mdl-32424363
2.
Single-cell protein expression profiling resolves circulating and resident memory T cell diversity across tissues and infection contexts.
Immunity
; 56(7): 1664-1680.e9, 2023 07 11.
Artigo
Inglês
| MEDLINE | ID: mdl-37392736
3.
FOXO1 enhances CAR T cell stemness, metabolic fitness and efficacy.
Nature
; 629(8010): 201-210, 2024 May.
Artigo
Inglês
| MEDLINE | ID: mdl-38600376
4.
IL-15 Preconditioning Augments CAR T Cell Responses to Checkpoint Blockade for Improved Treatment of Solid Tumors.
Mol Ther
; 28(11): 2379-2393, 2020 11 04.
Artigo
Inglês
| MEDLINE | ID: mdl-32735774
5.
Targeting Epstein-Barr virus-transformed B lymphoblastoid cells using antibodies with T-cell receptor-like specificities.
Blood
; 128(10): 1396-407, 2016 09 08.
Artigo
Inglês
| MEDLINE | ID: mdl-27338099
6.
The NLRP3 inflammasome affects DNA damage responses after oxidative and genotoxic stress in dendritic cells.
Eur J Immunol
; 43(8): 2126-37, 2013 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-23619996
7.
CD28-CAR-T cell activation through FYN kinase signaling rather than LCK enhances therapeutic performance.
Cell Rep Med
; 4(2): 100917, 2023 02 21.
Artigo
Inglês
| MEDLINE | ID: mdl-36696897
8.
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Cell Rep
; 42(8): 113014, 2023 08 29.
Artigo
Inglês
| MEDLINE | ID: mdl-37605534
9.
A2AR eGFP reporter mouse enables elucidation of A2AR expression dynamics during anti-tumor immune responses.
Nat Commun
; 14(1): 6990, 2023 11 01.
Artigo
Inglês
| MEDLINE | ID: mdl-37914685
10.
Inhibition of the CtBP complex and FBXO11 enhances MHC class II expression and anti-cancer immune responses.
Cancer Cell
; 40(10): 1190-1206.e9, 2022 10 10.
Artigo
Inglês
| MEDLINE | ID: mdl-36179686
11.
Augmenting Adoptive T-cell Immunotherapy by Targeting the PD-1/PD-L1 Axis.
Cancer Res
; 81(23): 5803-5805, 2021 12 01.
Artigo
Inglês
| MEDLINE | ID: mdl-34853040
12.
Cellular networks controlling T cell persistence in adoptive cell therapy.
Nat Rev Immunol
; 21(12): 769-784, 2021 12.
Artigo
Inglês
| MEDLINE | ID: mdl-33879873
13.
Characterization and Establishment of a Novel EBV Strain Simultaneously Associated With Nasopharyngeal Carcinoma and B-Cell Lymphoma.
Front Oncol
; 11: 626659, 2021.
Artigo
Inglês
| MEDLINE | ID: mdl-33898307
14.
Targeting CAR to the Peptide-MHC Complex Reveals Distinct Signaling Compared to That of TCR in a Jurkat T Cell Model.
Cancers (Basel)
; 13(4)2021 Feb 18.
Artigo
Inglês
| MEDLINE | ID: mdl-33670734
15.
CRISPR/Cas9 mediated deletion of the adenosine A2A receptor enhances CAR T cell efficacy.
Nat Commun
; 12(1): 3236, 2021 05 28.
Artigo
Inglês
| MEDLINE | ID: mdl-34050151
16.
MAIT cells regulate NK cell-mediated tumor immunity.
Nat Commun
; 12(1): 4746, 2021 08 06.
Artigo
Inglês
| MEDLINE | ID: mdl-34362900
17.
Macrophage-Derived CXCL9 and CXCL10 Are Required for Antitumor Immune Responses Following Immune Checkpoint Blockade.
Clin Cancer Res
; 26(2): 487-504, 2020 01 15.
Artigo
Inglês
| MEDLINE | ID: mdl-31636098
18.
Switching on the green light for chimeric antigen receptor T-cell therapy.
Clin Transl Immunology
; 8(5): e1046, 2019.
Artigo
Inglês
| MEDLINE | ID: mdl-31073403
19.
CRISPR-Cas9 screening identifies an IRF1-SOCS1-mediated negative feedback loop that limits CXCL9 expression and antitumor immunity.
Cell Rep
; 43(2): 113793, 2024 Feb 27.
Artigo
Inglês
| MEDLINE | ID: mdl-38324452
20.
Dual PD-1 and CTLA-4 Checkpoint Blockade Promotes Antitumor Immune Responses through CD4+Foxp3- Cell-Mediated Modulation of CD103+ Dendritic Cells.
Cancer Immunol Res
; 6(9): 1069-1081, 2018 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30018045